8-K ·Filed Jun 15, 2026

COR

Cencora, Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed3mo ago SEC0001104659-26-074102
8-K context-dependent: Items 5.02, 7.01
Actionable Insight • Neutral

No trading signal from this filing. Monitor for any unexpected departures in the C-suite or changes to strategic direction, but this succession appears orderly and non-disruptive.

DirectionNeutral
Confidencehigh
Horizonimmediate
Final — all horizons settled through T+60d
COR ▲ +14.03% at T+60d
NEUTRAL call ✓ call won +14.03% · α vs SPY +13.03% · entry $281.46 → $320.95
Entry anchored
Jun 15, 03:59 PM ET
via exchange tick
T+1d
-1.55%
call -1.55% · α -0.30%
$277.09
settled 4mo ago
T+5d
-0.13%
call -0.13% · α +2.10%
$281.10
settled 3mo ago
T+20d
+7.40%
call +7.40% · α +7.20%
$302.28
settled 3mo ago
T+60d
+14.03%
call +14.03% · α +13.03%
$320.95
settled 22d ago

Price Chart

Loading chart...

Executive Summary

Cencora announced the retirement of EVP and CHRO Silvana Battaglia effective July 12, 2026, with Samantha Hammock (former Verizon CHRO) succeeding her on July 13. The transition includes an advisory period through year-end, and the filing explicitly states the retirement was not due to any disagreement. This is a routine leadership succession with no financial or operational implications.

Key Facts

  • Silvana Battaglia to retire as EVP and CHRO effective July 12, 2026
  • Samantha Hammock appointed as EVP and CHRO effective July 13, 2026
  • Hammock most recently served as EVP and CHRO of Verizon Communications
  • Battaglia will serve in an advisory capacity through end of 2026
  • Retirement was not the result of any disagreement on operations, policies, or practices

Financial Impact

No financial impact; routine executive succession

Risk Factors

  • Potential short-term distraction during transition period
  • Integration risk if Hammock's strategy differs from Battaglia's

Market Snapshot

Exchange
NYSE
Sector
Wholesale-Drugs, Proprietaries & Druggists' Sundries
Analyst Consensus
80% bullish (20 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001104659-26-074102
Document: tm2617954d1_ex99-1.htm0001104659-26-074102
Document: 0001104659-26-074102-index-headers.html0001104659-26-074102
Document: 0001104659-26-074102-index.html0001104659-26-074102
Document: 0001104659-26-074102.txt0001104659-26-074102
7 reports for COR
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for COR — sortable, filterable
TypeNow
Aug 21, 2026
6w ago
Institutional Cluster
MIXED ★ 6/10
$318.04 $308.78▼ −2.91%▼ −2.63%$304.47 (−4.27%)
Aug 5, 2026
8w ago
8-K
NEUTRAL ★ 3/10
$317.22 $336.36▲ +6.03%▲ +6.64%$304.47 (−4.02%)
Aug 5, 2026
8w ago
8-K
BULLISH ★ 6/10
$317.22 $336.36▲ +6.03%▲ +6.64%$304.47 (−4.02%)
Jun 15, 2026
15w ago
8-K
NEUTRAL ★ 2/10
$281.46 $302.28▲ +7.40%▲ +7.20%$304.47 (+8.18%)
May 29, 2026
17w ago
8-K
NEUTRAL ★ 3/10
$264.69 $282.98▲ +6.91%▲ +8.21%$304.47 (+15.03%)
May 6, 2026
21w ago
8-K
NEUTRAL ★ 5/10
$252.74 $263.64▲ +4.31%▲ +1.53%$304.47 (+20.47%)
Feb 28, 2026
30w ago
Institutional Cluster
BULLISH ★ 8/10
$372.65 $309.93▼ −16.83%▼ −8.89%$304.47 (−18.30%)
Showing 7 of 7

US Market Status

Market Open — Closes in 6h 24m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access